Esperion Therapeutics Inc (ESPR)
2.59
+0.29
(+12.61%)
USD |
NASDAQ |
May 16, 16:00
2.63
+0.04
(+1.54%)
After-Hours: 20:00
Esperion Therapeutics 1 Year Total Returns (Daily): 35.29% for May 15, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 15, 2024 | 35.29% |
May 14, 2024 | 41.56% |
May 13, 2024 | 44.81% |
May 10, 2024 | 50.00% |
May 09, 2024 | 47.18% |
May 08, 2024 | 51.11% |
May 07, 2024 | 69.29% |
May 06, 2024 | 51.43% |
May 03, 2024 | 52.94% |
May 02, 2024 | 56.06% |
May 01, 2024 | 43.66% |
April 30, 2024 | 49.24% |
April 29, 2024 | 50.76% |
April 26, 2024 | 57.02% |
April 25, 2024 | 65.83% |
April 24, 2024 | 74.59% |
April 23, 2024 | 63.28% |
April 22, 2024 | 49.22% |
April 19, 2024 | 48.86% |
April 18, 2024 | 41.67% |
April 17, 2024 | 34.31% |
April 16, 2024 | 52.80% |
April 15, 2024 | 54.80% |
April 12, 2024 | 65.89% |
April 11, 2024 | 86.29% |
Date | Value |
---|---|
April 10, 2024 | 83.94% |
April 09, 2024 | 105.1% |
April 08, 2024 | 122.8% |
April 05, 2024 | 157.1% |
April 04, 2024 | 127.0% |
April 03, 2024 | 102.6% |
April 02, 2024 | 81.13% |
April 01, 2024 | 75.47% |
March 28, 2024 | 52.27% |
March 27, 2024 | 55.95% |
March 26, 2024 | 68.75% |
March 25, 2024 | 63.75% |
March 22, 2024 | 56.85% |
March 21, 2024 | 38.82% |
March 20, 2024 | 42.21% |
March 19, 2024 | 34.19% |
March 18, 2024 | 32.26% |
March 15, 2024 | -47.99% |
March 14, 2024 | -49.00% |
March 13, 2024 | -48.59% |
March 12, 2024 | -55.14% |
March 11, 2024 | -53.61% |
March 08, 2024 | -56.29% |
March 07, 2024 | -53.52% |
March 06, 2024 | -51.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.98%
Minimum
Oct 26 2023
157.1%
Maximum
Apr 05 2024
-34.16%
Average
-43.67%
Median
1 Year Total Returns (Daily) Benchmarks
United Therapeutics Corp | 28.38% |
Dynavax Technologies Corp | 0.98% |
Heron Therapeutics Inc | 125.6% |
Aldeyra Therapeutics Inc | -59.16% |
Deciphera Pharmaceuticals Inc | 78.97% |